Trending Now
Business
A Successful Opioid Settlement Could Put Endo In Play
In my opinion, Endo International (ENDP) is one of the more perplexing names in the stock market. Just when you think you have a...
Endo’s Effective Short Interest Reaches 200%
I am a major Endo (ENDP) bull. However, I would be remiss in not admitting that it has been one of the...
Lifestyle today
Entertainment
Mavyret Could Amplify Gilead’s HCV Pain
An HCV price war between Gilead (GILD) and AbbVie (ABBV) could heat up. AbbVie recently received FDA approval for Mavyret, its new HCV drug....
DopeSick, Jake Tapper Clap Back At Dr. Amarquaye Over Opioid crisis
America's drug epidemic is one of the ugliest, if not the ugliest in the country's history. Overdose deaths for the trailing 12...
Halliburton: Latin America Will Weigh Monday
Halliburton (HAL) reports Q4 earnings Monday. Analysts expect revenue of $5.63 billion and eps of $0.46. The revenue estimate implies a 3% increase sequentially....
Allergan: Growth Is Dead
Allergan's (AGN) Q2 results appeared to be pretty strong, at least on the surface. The company reported revenue of $4.0 billion and EBITDA of...
Sell Endo Into Earnings
Endo (ENDP) reports Q3 earnings Thursday. Analysts expect revenue of $784.6 million and eps of $1.01. The revenue estimate implies a 10% decline Q/Q....
Federal Judge Clears The Deck For Landmark Opioid Deal
Two years ago President Trump was highly critical of opioid drug manufacturers. He wanted to shed more light on their role in the opioid...
FIU Bridge Collapse Leaves Four Dead
It seems as if everyday you wake up to another tragedy around the world. From school shooting to police killings to military provocations it...
Was Yellen’s Jackson Hole Speech A Clap Back At Trump?
Fed Chairwoman Janet Yellen delivered her much-anticipated Jackson Hole speech last week. Financial markets were looking for Yellen to tip her hand on the...























































































































